Oneness Biotech Co., Ltd. (TPEX:4743)
Taiwan
· Delayed Price · Currency is TWD 52.80
+0.40 (0.76%)
Mar 10, 2026, 9:35 AM CST
Oneness Biotech Revenue
Oneness Biotech had revenue of 34.05M TWD in the quarter ending September 30, 2025, with 16.23% growth. This brings the company's revenue in the last twelve months to 117.33M, up 4.57% year-over-year. In the year 2024, Oneness Biotech had annual revenue of 117.93M with 35.89% growth.
Revenue (ttm)
117.33M
Revenue Growth
+4.57%
P/S Ratio
213.67
Revenue / Employee
2.73M
Employees
43
Market Cap
25.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 117.93M | 31.14M | 35.89% |
| Dec 31, 2023 | 86.78M | -978.77M | -91.86% |
| Dec 31, 2022 | 1.07B | 999.79M | 1,520.24% |
| Dec 31, 2021 | 65.77M | 24.16M | 58.07% |
| Dec 31, 2020 | 41.61M | 28.13M | 208.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lumosa Therapeutics | 35.83M |
| Polaris Group | 70.83M |
| Sunmax Biotechnology | 2.00B |
| Pell Bio-Med Technology | 29.99M |
| EirGenix | 936.18M |
| TaiMed Biologics | 607.22M |
| AP Biosciences | 32.25M |
| TCM Biotech International | 682.40M |